Recurrent thromboembolism in ovarian cancer.
Fuglsang
Jens
J
Center for Haemophilia and Thrombosis, Skejby Sygehus, Aarhus University Hospital, Aarhus, Denmark. Jens_Fuglsang@hotmail.com
Ingerslev
Jørgen
J
Havsteen
Hanne
H
D000925:Anticoagulants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018284:Cystadenocarcinoma, Serous / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000150:complications* / Q000188:drug therapy; D012008:Recurrence; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D000970:Antineoplastic Agents; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin